Cargando…
Brain Dopamine Transmission in Health and Parkinson's Disease: Modulation of Synaptic Transmission and Plasticity Through Volume Transmission and Dopamine Heteroreceptors
This perspective article provides observations supporting the view that nigro-striatal dopamine neurons and meso-limbic dopamine neurons mainly communicate through short distance volume transmission in the um range with dopamine diffusing into extrasynaptic and synaptic regions of glutamate and GABA...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048293/ https://www.ncbi.nlm.nih.gov/pubmed/30042672 http://dx.doi.org/10.3389/fnsyn.2018.00020 |
_version_ | 1783340089996214272 |
---|---|
author | Borroto-Escuela, Dasiel O. Perez De La Mora, Miguel Manger, Paul Narváez, Manuel Beggiato, Sarah Crespo-Ramírez, Minerva Navarro, Gemma Wydra, Karolina Díaz-Cabiale, Zaida Rivera, Alicia Ferraro, Luca Tanganelli, Sergio Filip, Małgorzata Franco, Rafael Fuxe, Kjell |
author_facet | Borroto-Escuela, Dasiel O. Perez De La Mora, Miguel Manger, Paul Narváez, Manuel Beggiato, Sarah Crespo-Ramírez, Minerva Navarro, Gemma Wydra, Karolina Díaz-Cabiale, Zaida Rivera, Alicia Ferraro, Luca Tanganelli, Sergio Filip, Małgorzata Franco, Rafael Fuxe, Kjell |
author_sort | Borroto-Escuela, Dasiel O. |
collection | PubMed |
description | This perspective article provides observations supporting the view that nigro-striatal dopamine neurons and meso-limbic dopamine neurons mainly communicate through short distance volume transmission in the um range with dopamine diffusing into extrasynaptic and synaptic regions of glutamate and GABA synapses. Based on this communication it is discussed how volume transmission modulates synaptic glutamate transmission onto the D1R modulated direct and D2R modulated indirect GABA pathways of the dorsal striatum. Each nigro-striatal dopamine neuron was first calculated to form large numbers of neostriatal DA nerve terminals and then found to give rise to dense axonal arborizations spread over the neostriatum, from which dopamine is released. These neurons can through DA volume transmission directly influence not only the striatal GABA projection neurons but all the striatal cell types in parallel. It includes the GABA nerve cells forming the island-/striosome GABA pathway to the nigral dopamine cells, the striatal cholinergic interneurons and the striatal GABA interneurons. The dopamine modulation of the different striatal nerve cell types involves the five dopamine receptor subtypes, D1R to D5R receptors, and their formation of multiple extrasynaptic and synaptic dopamine homo and heteroreceptor complexes. These features of the nigro-striatal dopamine neuron to modulate in parallel the activity of practically all the striatal nerve cell types in the dorsal striatum, through the dopamine receptor complexes allows us to understand its unique and crucial fine-tuning of movements, which is lost in Parkinson's disease. Integration of striatal dopamine signals with other transmitter systems in the striatum mainly takes place via the receptor-receptor interactions in dopamine heteroreceptor complexes. Such molecular events also participate in the integration of volume transmission and synaptic transmission. Dopamine modulation of the glutamate synapses on the dorsal striato-pallidal GABA pathway involves D2R heteroreceptor complexes such as D2R-NMDAR, A2AR-D2R, and NTSR1-D2R heteroreceptor complexes. The dopamine modulation of glutamate synapses on the striato-entopeduncular/nigral pathway takes place mainly via D1R heteroreceptor complexes such as D1R-NMDAR, A2R-D1R, and D1R-D3R heteroreceptor complexes. Dopamine modulation of the island/striosome compartment of the dorsal striatum projecting to the nigral dopamine cells involve D4R-MOR heteroreceptor complexes. All these receptor-receptor interactions have relevance for Parkinson's disease and its treatment. |
format | Online Article Text |
id | pubmed-6048293 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-60482932018-07-24 Brain Dopamine Transmission in Health and Parkinson's Disease: Modulation of Synaptic Transmission and Plasticity Through Volume Transmission and Dopamine Heteroreceptors Borroto-Escuela, Dasiel O. Perez De La Mora, Miguel Manger, Paul Narváez, Manuel Beggiato, Sarah Crespo-Ramírez, Minerva Navarro, Gemma Wydra, Karolina Díaz-Cabiale, Zaida Rivera, Alicia Ferraro, Luca Tanganelli, Sergio Filip, Małgorzata Franco, Rafael Fuxe, Kjell Front Synaptic Neurosci Neuroscience This perspective article provides observations supporting the view that nigro-striatal dopamine neurons and meso-limbic dopamine neurons mainly communicate through short distance volume transmission in the um range with dopamine diffusing into extrasynaptic and synaptic regions of glutamate and GABA synapses. Based on this communication it is discussed how volume transmission modulates synaptic glutamate transmission onto the D1R modulated direct and D2R modulated indirect GABA pathways of the dorsal striatum. Each nigro-striatal dopamine neuron was first calculated to form large numbers of neostriatal DA nerve terminals and then found to give rise to dense axonal arborizations spread over the neostriatum, from which dopamine is released. These neurons can through DA volume transmission directly influence not only the striatal GABA projection neurons but all the striatal cell types in parallel. It includes the GABA nerve cells forming the island-/striosome GABA pathway to the nigral dopamine cells, the striatal cholinergic interneurons and the striatal GABA interneurons. The dopamine modulation of the different striatal nerve cell types involves the five dopamine receptor subtypes, D1R to D5R receptors, and their formation of multiple extrasynaptic and synaptic dopamine homo and heteroreceptor complexes. These features of the nigro-striatal dopamine neuron to modulate in parallel the activity of practically all the striatal nerve cell types in the dorsal striatum, through the dopamine receptor complexes allows us to understand its unique and crucial fine-tuning of movements, which is lost in Parkinson's disease. Integration of striatal dopamine signals with other transmitter systems in the striatum mainly takes place via the receptor-receptor interactions in dopamine heteroreceptor complexes. Such molecular events also participate in the integration of volume transmission and synaptic transmission. Dopamine modulation of the glutamate synapses on the dorsal striato-pallidal GABA pathway involves D2R heteroreceptor complexes such as D2R-NMDAR, A2AR-D2R, and NTSR1-D2R heteroreceptor complexes. The dopamine modulation of glutamate synapses on the striato-entopeduncular/nigral pathway takes place mainly via D1R heteroreceptor complexes such as D1R-NMDAR, A2R-D1R, and D1R-D3R heteroreceptor complexes. Dopamine modulation of the island/striosome compartment of the dorsal striatum projecting to the nigral dopamine cells involve D4R-MOR heteroreceptor complexes. All these receptor-receptor interactions have relevance for Parkinson's disease and its treatment. Frontiers Media S.A. 2018-07-10 /pmc/articles/PMC6048293/ /pubmed/30042672 http://dx.doi.org/10.3389/fnsyn.2018.00020 Text en Copyright © 2018 Borroto-Escuela, Perez De La Mora, Manger, Narváez, Beggiato, Crespo-Ramírez, Navarro, Wydra, Díaz-Cabiale, Rivera, Ferraro, Tanganelli, Filip, Franco and Fuxe. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Borroto-Escuela, Dasiel O. Perez De La Mora, Miguel Manger, Paul Narváez, Manuel Beggiato, Sarah Crespo-Ramírez, Minerva Navarro, Gemma Wydra, Karolina Díaz-Cabiale, Zaida Rivera, Alicia Ferraro, Luca Tanganelli, Sergio Filip, Małgorzata Franco, Rafael Fuxe, Kjell Brain Dopamine Transmission in Health and Parkinson's Disease: Modulation of Synaptic Transmission and Plasticity Through Volume Transmission and Dopamine Heteroreceptors |
title | Brain Dopamine Transmission in Health and Parkinson's Disease: Modulation of Synaptic Transmission and Plasticity Through Volume Transmission and Dopamine Heteroreceptors |
title_full | Brain Dopamine Transmission in Health and Parkinson's Disease: Modulation of Synaptic Transmission and Plasticity Through Volume Transmission and Dopamine Heteroreceptors |
title_fullStr | Brain Dopamine Transmission in Health and Parkinson's Disease: Modulation of Synaptic Transmission and Plasticity Through Volume Transmission and Dopamine Heteroreceptors |
title_full_unstemmed | Brain Dopamine Transmission in Health and Parkinson's Disease: Modulation of Synaptic Transmission and Plasticity Through Volume Transmission and Dopamine Heteroreceptors |
title_short | Brain Dopamine Transmission in Health and Parkinson's Disease: Modulation of Synaptic Transmission and Plasticity Through Volume Transmission and Dopamine Heteroreceptors |
title_sort | brain dopamine transmission in health and parkinson's disease: modulation of synaptic transmission and plasticity through volume transmission and dopamine heteroreceptors |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048293/ https://www.ncbi.nlm.nih.gov/pubmed/30042672 http://dx.doi.org/10.3389/fnsyn.2018.00020 |
work_keys_str_mv | AT borrotoescueladasielo braindopaminetransmissioninhealthandparkinsonsdiseasemodulationofsynaptictransmissionandplasticitythroughvolumetransmissionanddopamineheteroreceptors AT perezdelamoramiguel braindopaminetransmissioninhealthandparkinsonsdiseasemodulationofsynaptictransmissionandplasticitythroughvolumetransmissionanddopamineheteroreceptors AT mangerpaul braindopaminetransmissioninhealthandparkinsonsdiseasemodulationofsynaptictransmissionandplasticitythroughvolumetransmissionanddopamineheteroreceptors AT narvaezmanuel braindopaminetransmissioninhealthandparkinsonsdiseasemodulationofsynaptictransmissionandplasticitythroughvolumetransmissionanddopamineheteroreceptors AT beggiatosarah braindopaminetransmissioninhealthandparkinsonsdiseasemodulationofsynaptictransmissionandplasticitythroughvolumetransmissionanddopamineheteroreceptors AT cresporamirezminerva braindopaminetransmissioninhealthandparkinsonsdiseasemodulationofsynaptictransmissionandplasticitythroughvolumetransmissionanddopamineheteroreceptors AT navarrogemma braindopaminetransmissioninhealthandparkinsonsdiseasemodulationofsynaptictransmissionandplasticitythroughvolumetransmissionanddopamineheteroreceptors AT wydrakarolina braindopaminetransmissioninhealthandparkinsonsdiseasemodulationofsynaptictransmissionandplasticitythroughvolumetransmissionanddopamineheteroreceptors AT diazcabialezaida braindopaminetransmissioninhealthandparkinsonsdiseasemodulationofsynaptictransmissionandplasticitythroughvolumetransmissionanddopamineheteroreceptors AT riveraalicia braindopaminetransmissioninhealthandparkinsonsdiseasemodulationofsynaptictransmissionandplasticitythroughvolumetransmissionanddopamineheteroreceptors AT ferraroluca braindopaminetransmissioninhealthandparkinsonsdiseasemodulationofsynaptictransmissionandplasticitythroughvolumetransmissionanddopamineheteroreceptors AT tanganellisergio braindopaminetransmissioninhealthandparkinsonsdiseasemodulationofsynaptictransmissionandplasticitythroughvolumetransmissionanddopamineheteroreceptors AT filipmałgorzata braindopaminetransmissioninhealthandparkinsonsdiseasemodulationofsynaptictransmissionandplasticitythroughvolumetransmissionanddopamineheteroreceptors AT francorafael braindopaminetransmissioninhealthandparkinsonsdiseasemodulationofsynaptictransmissionandplasticitythroughvolumetransmissionanddopamineheteroreceptors AT fuxekjell braindopaminetransmissioninhealthandparkinsonsdiseasemodulationofsynaptictransmissionandplasticitythroughvolumetransmissionanddopamineheteroreceptors |